Witness Credibility Analysis
AI Pricing Tools in Senior Care: The Antitrust Risks You Need to Manage Now
Senior living and nursing home operators increasingly lean on third-party “revenue management” software to set rates, discounts, and co...
California Explicitly Bars Algorithmic Price Collusion, Raises Antitrust Penalties
On New Year’s Day laws go into effect in California that are intended to modernize and strengthen the Cartwright Act, the state’s prima...
Healthcare & Life Sciences: Drug Pricing Digest – November 2025
Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Pro...
The Fourth Circuit Used a Data Breach on the Dark Web to Illuminate the Boundaries of Standing
Since the Supreme Court’s opinion in TransUnion LLC v. Ramirez, 594 U.S. 413 (2021), litigants and courts alike have struggled to deter...
Your Law Firm AI Strategy Is Failing Because Your Data and Systems Are Garbage
Law firms are making the same mistake with AI that they made with cloud computing, practice management software, and every other techno...
AI in Hiring: Hidden Compliance Risks for Employers
Artificial intelligence is transforming how employers recruit and evaluate talent. According to industry research, the percentage of HR...
California AG Announces Another CCPA Enforcement Action: Part 1
The California AG’s fifth CCPA-related enforcement action focuses on the CCPA’s right to opt out of sales/shares and on children’s priv...
Latest Federal Court Cases: Merck Serono S.A. v. Hopewell Pharma Ventures, Inc.
Merck Serono S.A. v. Hopewell Pharma Ventures, Inc., Appeal Nos. 2025-1210, -1211 (Fed. Cir. Oct. 30, 2025) - In our Case of the Week...
Fed’s Waller Floats “Payment Accounts” to Streamline Access to Fed Rails: What a “Skinny” Account Could Mean for Payments and Digital Assets
Federal Reserve Governor Christopher J. Waller used the central bank’s inaugural Payments Innovation Conference on October 21 to propos...
Prefilled Syringe Presentation of GSK’s SHINGRIX Receives Positive CHMP Opinion
On October 21, 2025, GSK announced that the European Medicine Agency’s (“EMA”) Committee for Medicinal Products for Human Use (“CHMP”) ...